| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | ENVISION HEALTHCARE HLDGS INC | 570,000 | 22,504,000 | 1.64% | ||
| 102 | CELGENE CORP | 198,000 | 22,916,000 | 1.67% | ||
| 103 | THORATEC LABS CORP | 532,500 | 23,734,000 | 1.73% | ||
| 104 | AMGEN INC | 156,000 | 23,949,000 | 1.75% | ||
| 105 | HUMANA INC | 131,500 | 25,153,000 | 1.84% | ||
| 106 | PFIZER INC | 760,000 | 25,483,000 | 1.86% | ||
| 107 | ALEXION PHARMACEUTIC | 154,500 | 27,929,000 | 2.04% | ||
| 108 | RADIUS HEALTH INCORPORATED COM NEW | 429,000 | 29,043,000 | 2.12% | ||
| 109 | GILEAD SCIENCES INC | 257,500 | 30,148,000 | 2.20% | ||
| 110 | SPARK THERAPEUTICS INCORPORATED | 508,059 | 30,621,000 | 2.24% | ||
| 111 | MCKESSON CORP | 149,500 | 33,609,000 | 2.45% | ||
| 112 | ALLERGAN PLC | 121,500 | 36,870,000 | 2.69% | ||
| 113 | HCA HOLDINGS INC | 422,500 | 38,329,000 | 2.80% | ||
| 114 | ACADIA COMPANY COM | 511,750 | 40,085,000 | 2.93% | ||
| 115 | VALEANT PHARMACEUTICALS INTL | 189,250 | 42,042,000 | 3.07% | ||
| 116 | MEDTRONIC PLC | 570,000 | 42,237,000 | 3.08% | ||
| 117 | ABBVIE INC | 746,423 | 50,152,000 | 3.66% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-15-001627, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
